Monday, April 2, 2018
Single-cell mRNA cytometry via sequence-specific nanoparticle clustering and trapping
Researchers have developed a new technology for a 'liquid biopsy' to identify which patients might not respond to standard therapy for prostate cancer before it is delivered.
Researchers seek to improve quality control for nanomanufacturing
New monitoring tool would be able to detect imperfections almost instantaneousl.
Newer Posts
Older Posts
Home
Subscribe to:
Posts (Atom)